EGFR and neoplasm: Next-generation sequencing (NGS) of tumor biopsies has greatly expanded our knowledge on somatic mutations in NSCLC such as the deep genetic heterogeneity in tumors beyond epidermal growth factor receptor (EGFR) changes [8].